387 related articles for article (PubMed ID: 30209635)
21. Relationship between left atrial volume and ischemic stroke subtype.
Kamel H; Okin PM; Merkler AE; Navi BB; Campion TR; Devereux RB; Díaz I; Weinsaft JW; Kim J
Ann Clin Transl Neurol; 2019 Aug; 6(8):1480-1486. PubMed ID: 31402612
[TBL] [Abstract][Full Text] [Related]
22. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
Segal JB; McNamara RL; Miller MR; Powe NR; Goodman SN; Robinson KA; Bass EB
Cochrane Database Syst Rev; 2001; (1):CD001938. PubMed ID: 11279741
[TBL] [Abstract][Full Text] [Related]
23. [Role of transesophageal echography in the study of embolism of cardiac origin].
Arrigo F; Carerj S; Pizzimenti G
Cardiologia; 1993 Dec; 38(12 Suppl 1):301-17. PubMed ID: 8020030
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight.
Hohnloser SH; Fudim M; Alexander JH; Wojdyla DM; Ezekowitz JA; Hanna M; Atar D; Hijazi Z; Bahit MC; Al-Khatib SM; Lopez-Sendon JL; Wallentin L; Granger CB; Lopes RD
Circulation; 2019 May; 139(20):2292-2300. PubMed ID: 30773022
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers Associated with Bleeding Risk in the Setting of Atrial Fibrillation.
Sideris S; Archontakis S; Latsios G; Lazaros G; Toutouzas K; Tsiamis E; Vavuranakis M; Vlachopoulos C; Gatzoulis K; Tsioufis C; Tousoulis D
Curr Med Chem; 2019; 26(5):824-836. PubMed ID: 28721832
[TBL] [Abstract][Full Text] [Related]
26. [Stroke and other thromboembolic complications of atrial fibrillation. Part VI. Choice of optimal approach and drugs for prevention of stroke].
Preobrazhenskiĭ DV; Sidorenko BA; Kiktëv VG; Batyraliev TA; Pershukov IV
Kardiologiia; 2005; 45(1):84-93. PubMed ID: 15699946
[TBL] [Abstract][Full Text] [Related]
27. Cardioembolic Stroke: Past Advancements, Current Challenges, and Future Directions.
Kato Y; Tsutsui K; Nakano S; Hayashi T; Suda S
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891965
[TBL] [Abstract][Full Text] [Related]
28. Left atrial size and risk of stroke in patients in sinus rhythm. A systematic review.
Overvad TF; Nielsen PB; Larsen TB; Søgaard P
Thromb Haemost; 2016 Aug; 116(2):206-19. PubMed ID: 27075168
[TBL] [Abstract][Full Text] [Related]
29. Atrial Cardiopathy and Cryptogenic Stroke.
Kato Y; Takahashi S
Front Neurol; 2022; 13():839398. PubMed ID: 35273560
[TBL] [Abstract][Full Text] [Related]
30. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators.
Zabalgoitia M; Halperin JL; Pearce LA; Blackshear JL; Asinger RW; Hart RG
J Am Coll Cardiol; 1998 Jun; 31(7):1622-6. PubMed ID: 9626843
[TBL] [Abstract][Full Text] [Related]
31. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.
Yan BP; Kiernan TJ; Gonzales-Cruz I; Lam YY
Expert Rev Med Devices; 2009 Nov; 6(6):611-20. PubMed ID: 19911873
[TBL] [Abstract][Full Text] [Related]
32. Lessons from the Stroke Prevention in Atrial Fibrillation trials.
Hart RG; Halperin JL; Pearce LA; Anderson DC; Kronmal RA; McBride R; Nasco E; Sherman DG; Talbert RL; Marler JR;
Ann Intern Med; 2003 May; 138(10):831-8. PubMed ID: 12755555
[TBL] [Abstract][Full Text] [Related]
33. Prevention of thromboembolic complication in atrial fibrillation by using anticoagulants.
Wagh K; Vikhe VB; Kumar RS; Auti N; Jose M
J Assoc Physicians India; 2013 Dec; 61(12):894-5. PubMed ID: 24968545
[TBL] [Abstract][Full Text] [Related]
34. [Anticoagulation in atrial fibrillation. Strategies in special situations].
Volkmann H; Walter M; Walter C; Vetter S
Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
[TBL] [Abstract][Full Text] [Related]
35. Cardioembolic Stroke.
Kamel H; Healey JS
Circ Res; 2017 Feb; 120(3):514-526. PubMed ID: 28154101
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
Grosset-Janin D; Barth E; Bertrand B; Detante O
Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
[TBL] [Abstract][Full Text] [Related]
37. [Stroke and other tromboembolic complications in atrial fibrillation. Part I. Prevalence and risk factors].
Preobrazhenskiĭ DV; Sidorenko BA; Kiktev VG; Batyraliev TA; Pershukov IV
Kardiologiia; 2004; 44(3):83-6. PubMed ID: 15489850
[TBL] [Abstract][Full Text] [Related]
38. Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal.
Marsico F; Cecere M; Parente A; Paolillo S; de Martino F; Dellegrottaglie S; Trimarco B; Perrone Filardi P
J Thromb Thrombolysis; 2017 Feb; 43(2):139-148. PubMed ID: 27614756
[TBL] [Abstract][Full Text] [Related]
39. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation.
Blackshear JL; Johnson WD; Odell JA; Baker VS; Howard M; Pearce L; Stone C; Packer DL; Schaff HV
J Am Coll Cardiol; 2003 Oct; 42(7):1249-52. PubMed ID: 14522490
[TBL] [Abstract][Full Text] [Related]
40. Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study.
Stöllberger C; Chnupa P; Abzieher C; Länger T; Finsterer J; Klem I; Hartl E; Wehinger C; Schneider B
Clin Cardiol; 2004 Jan; 27(1):40-6. PubMed ID: 14743856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
